Published 1 year ago

FDA inspection uncovers cherry-colored antibiotic residue on equipment at Teva’s New Jersey site – Pennsylvania NY NJ Biotech Networks

Summary by Los Angeles Biotechnology Network

An FDA inspection report on Teva’s manufacturing site in New Jersey has revealed issues with both equipment cleaning and quality. The three-page report, which was obtained by Endpoints News via a FOIA request from the FDA, showed several observations f... [...]

0 Articles

All

Left

Center

Right

Pennsylvania NY NJ Biotech Networks

FDA inspection uncovers cherry-colored antibiotic residue on equipment at Teva’s New Jersey site – Pennsylvania NY NJ Biotech Networks

1 year ago

Read Full Article

Los Angeles Biotechnology Network

FDA inspection uncovers cherry-colored antibiotic residue on equipment at Teva's New Jersey site - Los Angeles Biotechnology Network

1 year ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated1 year agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

FDA inspection uncovers cherry-colored antibiotic residue on equipment at Teva’s New Jersey site – Pennsylvania NY NJ Biotech Networks

0 Articles

0 Articles

FDA inspection uncovers cherry-colored antibiotic residue on equipment at Teva’s New Jersey site – Pennsylvania NY NJ Biotech Networks

FDA inspection uncovers cherry-colored antibiotic residue on equipment at Teva’s New Jersey site – Pennsylvania NY NJ Biotech Networks

FDA inspection uncovers cherry-colored antibiotic residue on equipment at Teva's New Jersey site - Los Angeles Biotechnology Network

FDA inspection uncovers cherry-colored antibiotic residue on equipment at Teva's New Jersey site - Los Angeles Biotechnology Network

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics